← All companies

MESO

Mesoblast Limited

MESO Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$14.47

-0.08 -0.55%

Key statistics

from XBRL data in SEC filings

Market cap

$18.5B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$12.66 – $21.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 30, 2026 6-K Jul 21, 2026 6-K Jul 15, 2026 6-K Jul 14, 2026 6-K Jul 10, 2026 6-K Jul 1, 2026 6-K Jun 25, 2026 6-K Jun 10, 2026 6-K Apr 30, 2026 6-K Apr 29, 2026 6-K Apr 17, 2026 6-K Apr 15, 2026 6-K Apr 8, 2026 6-K Apr 8, 2026 6-K Apr 8, 2026 6-K Apr 8, 2026 6-K Mar 23, 2026 6-K Mar 18, 2026 6-K Mar 13, 2026 6-K Mar 12, 2026 6-K Feb 27, 2026 6-K Feb 27, 2026 6-K Feb 23, 2026 6-K Feb 12, 2026 6-K Jan 29, 2026 6-K Jan 28, 2026 6-K Jan 21, 2026 6-K Jan 16, 2026 6-K Jan 14, 2026 6-K Jan 13, 2026 6-K Jan 9, 2026 6-K Jan 7, 2026 6-K Jan 2, 2026 6-K Dec 30, 2025 6-K Dec 29, 2025 6-K Dec 18, 2025 6-K Dec 12, 2025 6-K Dec 4, 2025 6-K Nov 26, 2025 6-K Nov 25, 2025